Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
No open-market purchases or sales by Taysha Gene Therapies, Inc. insiders were filed in the last 90 days; 204 institutions reported holding it in 13F filings for Q3 2026, worth $1.54B in total; no superinvestor holds it.
Holders of 5% or more of TSHA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Taysha Gene Therapies, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13G/A | 9.90%32.8M shares | 0.00 ppfrom 9.90% | Aug 25, 20237 filings | Nov 16, 2026 | SEC |
| Manning Paul B | 13D/A | 9.80%25.6M shares | – | Nov 2, 20223 filings | Jun 3, 2025 | SEC |
| RTW Investments, LP | 13G/A | 7.00%20.7M shares | −1.30 ppfrom 8.30% | Feb 14, 20246 filings | May 15, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.50%17.9M shares | +1.30 ppfrom 5.20% | Oct 22, 20244 filings | Jan 21, 2026 | SEC |
| Vestal Point Capital, LP | 13G/A | 6.30%18.0M shares | +1.30 ppfrom 5.00% | Feb 17, 20262 filings | May 15, 2026 | SEC |
| Morgan Stanley | 13G/A | 5.10%16.2M shares | −1.60 ppfrom 6.70% | Feb 5, 20253 filings | Aug 13, 2026 | SEC |
| Goldman Sachs Group Inc | 13G | 5.10%12.7M shares | New | Jul 3, 20251 filing | Jul 3, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
51 Schedule 13D and 13G filings on Taysha Gene Therapies, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20265:27 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%32.8M shares | 0.00 ppfrom 9.90% | Sep 30, 2026 | SEC |
| Aug 14, 20264:47 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%32.9M shares | 0.00 ppfrom 9.90% | Jun 30, 2026 | SEC |
| Aug 13, 20265:38 PM ET | Morgan Stanleyand 1 other | 13G/A | 5.10%16.2M shares | −1.60 ppfrom 6.70% | Jun 30, 2026 | SEC |
| May 15, 20265:09 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 6.30%18.0M shares | +1.30 ppfrom 5.00% | Mar 31, 2026 | SEC |
| May 15, 20268:36 AM ET | RTW Investments, LPand 1 other | 13G/A | 7.00%20.7M shares | −1.30 ppfrom 8.30% | Mar 31, 2026 | SEC |
| Feb 17, 20264:07 PM ET | Vestal Point Capital, LPand 1 other | 13G | 5.00%13.8M shares | New | Dec 31, 2025 | SEC |
| Feb 17, 20268:49 AM ET | RTW Investments, LPand 1 other | 13G/A | 8.30%23.4M shares | −1.60 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 5, 20261:40 PM ET | FMR LLCand 1 other | 13G/A | 4.90%13.5M shares | −1.30 ppfrom 6.20%Below 5% | Dec 31, 2025 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G/A | 6.50%17.9M shares | +1.30 ppfrom 5.20% | Dec 31, 2025 | SEC |
| Nov 14, 20254:46 PM ET | Octagon Capital Advisors LPand 2 others | 13G/A | 3.30%9.07M shares | −1.80 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:18 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%27.7M shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Aug 14, 20256:11 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%25.3M shares | – | Jun 30, 2025 | SEC |
| Aug 14, 20258:10 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.90%25.2M shares | −0.09 ppfrom 9.99% | Jun 30, 2025 | SEC |
| Aug 6, 20252:13 PM ET | Morgan Stanleyand 1 other | 13G/A | 6.70%16.9M shares | −1.90 ppfrom 8.60% | Jun 30, 2025 | SEC |
| Aug 6, 202512:14 PM ET | FMR LLCand 1 other | 13G/A | 6.20%15.6M shares | −1.80 ppfrom 8.00% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 5.20%13.2M shares | – | Jun 30, 2025 | SEC |
| Jul 3, 202512:23 PM ET | Goldman Sachs Group Incand 1 other | 13G | 5.10%12.7M shares | New | Jun 26, 2025 | SEC |
| Jun 3, 20259:54 PM ET | Manning Paul Band 5 others | 13D/A | 9.80%25.6M shares | – | May 30, 2025 | SEC |
| May 15, 20258:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.99%20.7M shares | +4.09 ppfrom 5.90% | Mar 31, 2025 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 5.90%12.4M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20259:22 AM ET | FMR LLCand 1 other | 13G/A | 8.00%16.4M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20256:05 PM ET | Octagon Capital Advisors LPand 2 others | 13G | 5.10%10.4M shares | New | Dec 31, 2024 | SEC |
| Feb 5, 202510:43 AM ET | Morgan Stanleyand 1 other | 13G | 8.60%17.6M shares | New | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Avoro Capital Advisors LLC | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | RTW Investments, LP | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | TCG Crossover GP I, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Sep 11, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Aug 28, 2023 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
| Aug 25, 2023 | TCG Crossover GP I, LLC | 13GOld format | – | New | – | SEC |
| Aug 25, 2023 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Aug 21, 2023 | Manning Paul B | 13D/AOld format | – | – | – | SEC |
| Aug 18, 2023 | Astellas Pharma Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 10, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 2, 2022 | Manning Paul B | 13D/AOld format | – | – | – | SEC |
| Oct 31, 2022 | Audentes Therapeutics, Inc. | 13DOld format | – | New | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 7, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Sep 24, 2021 | University of Texas/Texas Am Investment Managment Co | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | University of Texas/Texas Am Investment Managment Co | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
32 notices from officers, directors and other affiliates planning to sell Taysha Gene Therapies, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 10, 20264:21 PM ET | Nagendran SukumarOfficer | 200.0K | $1.30M | Jul 10, 202610b5-1 | Jefferies LLC | SEC |
| Apr 10, 20264:11 PM ET | Nagendran SukumarOfficer | 200.0K | $926.0K | Apr 10, 202610b5-1 | Jefferies LLC | SEC |
| Feb 27, 20264:07 PM ET | Rumana Haque-AhmedOfficer | 2.40K | $11.0K | Feb 27, 2026 | Maxim Group LLC | SEC |
| Feb 4, 20266:44 PM ET | Emily McGinnisAffiliate-Chief Pat. Adv. & Ext. Aff. Off. | 901 | $4.25K | Feb 4, 2026 | Maxim Group LLC | SEC |
| Feb 4, 20266:42 PM ET | Fred PorterAffiliate-Chief of Staff & Tech.Op.Officer | 889 | $4.20K | Feb 4, 2026 | Maxim Group LLC | SEC |
| Feb 4, 20266:41 PM ET | Sean McAuliffeAffiliate - Chief Business Officer | 914 | $4.31K | Feb 4, 2026 | Maxim Group LLC | SEC |
| Feb 4, 20266:39 PM ET | Rumana Haque-AhmedOfficer | 697 | $3.29K | Feb 4, 2026 | Maxim Group LLC | SEC |
| Feb 4, 20266:38 PM ET | Kamran AlamOfficer | 1.66K | $7.81K | Feb 4, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20268:07 PM ET | Sean P. NolanOfficer · Director | 168.1K | $855.5K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20268:05 PM ET | Sukumar NagendranOfficer | 113.8K | $579.4K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20268:04 PM ET | Rumana Haque-AhmedOfficer | 30.1K | $153.0K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20268:02 PM ET | Fred PorterAffiliate-Chief of Staff & Tech.Op.Officer | 54.9K | $279.5K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20268:01 PM ET | Emily McGinnisAffiliate-Chief Pat. Adv. & Ext. Aff. Off. | 32.1K | $163.3K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20267:59 PM ET | Sean McAuliffeAffiliate - Chief Business Officer | 46.1K | $234.5K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 23, 20267:58 PM ET | Kamran AlamOfficer | 100.8K | $513.3K | Jan 23, 2026 | Maxim Group LLC | SEC |
| Jan 12, 20264:19 PM ET | Nagendran SukumarOfficer | 200.0K | $996.0K | Jan 12, 202610b5-1 | Jefferies LLC | SEC |
| Nov 28, 20251:07 PM ET | Nagendran SukumarOfficer | 370.2K | $1.80M | Nov 28, 2025 | Jefferies LLC | SEC |
| Sep 22, 20257:18 PM ET | Rumana Haque-AhmedOfficer | 10.8K | $30.5K | Sep 22, 2025 | Maxim Group LLC | SEC |
| Sep 10, 20254:28 PM ET | Nagendran SukumarOfficer | 200.0K | $652.0K | Sep 10, 202510b5-1 | Jefferies LLC | SEC |
| Aug 21, 20259:12 PM ET | Kamran AlamOfficer | 54.5K | $156.4K | Aug 21, 2025 | Maxim Group LLC | SEC |
| Aug 21, 20259:11 PM ET | Emily McGinnisAffiliate-Chief Pat. Adv. & Ext. Aff. Off. | 19.6K | $56.3K | Aug 21, 2025 | Maxim Group LLC | SEC |
| Aug 21, 20259:10 PM ET | Sukumar NagendranOfficer · Director | 57.1K | $163.7K | Aug 21, 2025 | Maxim Group LLC | SEC |
| Aug 21, 20259:09 PM ET | Sean McAuliffeAffiliate - Chief Business Officer | 27.6K | $79.2K | Aug 21, 2025 | Maxim Group LLC | SEC |
| Aug 21, 20259:08 PM ET | Fred PorterAffiliate-Chief of Staff & Tech.Op.Officer | 50.5K | $144.8K | Aug 21, 2025 | Maxim Group LLC | SEC |
| Jul 5, 20245:51 PM ET | McGinnis EmilyAffiliate-Chief Pat. Advo. & Ext. Affairs Officer | 16.9K | $36.3K | Jul 5, 2024 | Maxim Group LLC | SEC |
Showing the latest 25. See the TSHA notices from the last 12 months